A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...
Despite the need, there are no FDA-approved medications to treat cannabis use disorder. AEF0117 is the first of a new pharmacologic class, type 1 cannabinoid receptor signaling-specific inhibitors ...
When patients undergo general anesthesia, doctors can choose among several drugs. Although each of these drugs acts on neurons in different ways, they all lead to the same result: a disruption of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results